RNA regulation of JAK-STAT pathways in CML

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Blinatumomab improves survival in ALL patients

Evaluation of ibrutinib in treatment of CLL with 17p deletion

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma

An overview of MCL from EHA 2016

The value and strategy for incorporating biosimilars Into clinical practice

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer

Sequencing analysis with circulating DNA

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.